Skip to main content
Bone & Joint Research logoLink to Bone & Joint Research
editorial
. 2016 Nov 9;5(10):490–491. doi: 10.1302/2046-3758.510.2000654

To operate or not to operate, that is the question

The proximal humerus fracture

M Ghert 1,, M McKee 2
PMCID: PMC5108352  PMID: 27760727

To operate or not to operate, that is the question. In the case of a displaced diaphyseal fracture of the femur, this question is not a challenge. We do not need a randomised controlled trial to determine if intramedullary nailing of a fracture of the femur is more effective, for any outcome, than months in traction. However, some fractures do not offer such a clear clinical decision-making opportunity. One such fracture that vexes the orthopaedic community is the proximal humerus fracture, especially in the elderly. As the human population continues to age, and life expectancy continues to extend towards the tenth decade, the fracture of the osteoporotic proximal humerus has become the focus of fierce debate.

A recent Cochrane Review1 and a subsequently published large multi-centre trial from the United Kingdom (PROximal Fracture of the Humerus: Evaluation by Randomisation (PROFHER) trial)2 have both concluded that in terms of shoulder function and quality of life, operative management does not appear to be more effective than non-operative treatment for fractures of the proximal humerus, particularly in the elderly. The Cochrane review assessed the evidence of included trials as ‘moderate or high’ and the PROFHER trial was published in one of the highest impact journals in the world. The evidence continues to mount, with further meta-analyses confirming these conclusions.3-5 With clinical adoption of this evidence, will surgical management of fractures of the proximal humerus become an historical entity?

In the May edition of Bone & Joint Research, Dean et al6 sampled a population of 110 patients treated surgically for a fracture of the proximal humerus over a defined period. Ten consecutive patients were included from each of 11 centres and reviewed retrospectively. The authors found that the majority of the patients met the inclusion criteria for the PROFHER trial and therefore perhaps could have been managed non-operatively with significant cost savings and no detriment to function or quality of life. Given the costs of surgical management,7,8 this conclusion has widespread pragmatic implications.

However, in reality the solution may not be that simple. The number of Neer four-part fractures in the PROFHER trial (11/250, 4.4%) was much lower than the 25% in the surgical population sample study by Dean et al, suggesting that generalisation of the results of the PROFHER trial may not be appropriate. Also, in the PROFHER study 66 surgeons operated on 125 patients over a two and a half year period, i.e., less than one patient per surgeon per year. It is hard to imagine this small proportion of patients being representative of all fractures of the proximal humeral at participating centres over this time frame. And, of greatest concern, there were a number of patients eligible for the PROFHER study that were excluded in the fine print because of an “associated dislocation” (100 patients), or because they had “clear indications for surgery” (87 patients). Thus, there were surgeons participating in this study who felt uneasy randomising certain patients to the potential for non-operative care. Intrinsically, we know that a healthy 50-year-old patient with an anterior fracture dislocation of the shoulder will do better with surgical intervention.

Lastly, there is significant residual disability and risk for complications in both operative and non-operative groups in these studies.1-5 There is clearly room for improvement. It may well be that improved implant designs and/or surgical techniques can enhance outcomes and justify surgical intervention for a greater proportion of patients. In addition, the standardisation of fracture pattern classification will help clarify an evidence-based approach to these patients.9

Thus, despite the fact that the evidence is suggesting that fractures of the proximal humerus may be treated effectively with conservative management, it is more likely that there are specific groups of patients that may indeed benefit from surgery. In fact, Sabharwal et al10 recently concluded in their study in Bone & Joint Research that the focus on specific fracture configurations and surgical techniques may need to be at the centre of future high-quality randomised trials, which will help determine ‘on whom to operate’, and not simply ‘to operate or not to operate’.

Footnotes

Author Contribution: M. Ghert: Editorial development and writing

M. McKee: Editorial conception, development and writing

ICMJE conflict of interest: None declared

Funding Statement

None declared

References

  • 1. Handoll HHG, Brorson S. Interventions for treating proximal humeral fractures in adults. Cochrane Database Syst Rev 2015;11:CD000434. [DOI] [PubMed] [Google Scholar]
  • 2. Rangan A, Handoll H, Brealey S, et al. Surgical vs nonsurgical treatment of adults with displaced fractures of the proximal humerus: the PROFHER randomized clinical trial. JAMA 2015;313:1037-1047. [DOI] [PubMed] [Google Scholar]
  • 3. Song JQ, Deng XF, Wang YM, et al. Operative vs. nonoperative treatment for comminuted proximal humeral fractures in elderly patients: a current meta-analysis. Acta Orthop Traumatol Turc 2015;49:345-353. [DOI] [PubMed] [Google Scholar]
  • 4. Rabi S, Evaniew N, Sprague SA, Bhandari M, Slobogean GP. Operative vs non-operative management of displaced proximal humeral fractures in the elderly: A systematic review and meta-analysis of randomized controlled trials. World J Orthop 2015;6:838-846. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Xie L, Ding F, Zhao Z, Chen Y, Xing D. Operative versus non-operative treatment in complex proximal humeral fractures: a meta-analysis of randomized controlled trials. Springer Plus 2015:4;728. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Dean BJF, Jones LD, Palmer AJR, et al. A review of current surgical practice in the operative treatment of proximal humeral fractures: does the PROFHER trial demonstrate a need for change? Bone Joint Res 2016;5:178-184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Sabharwal S, Carter AW, Rashid A, et al. Cost analysis of the surgical treatment of fractures of the proximal humerus: an evaluation of the determinants of cost and comparison of the institutional cost of treatment with the national tariff. Bone Joint J 2016;98-B:249-259. [DOI] [PubMed] [Google Scholar]
  • 8. Corbacho B, Duarte A, Keding A, et al. Cost effectiveness of surgical versus non-surgical treatment of adults with displaced fractures of the proximal humerus: economic evaluation alongside the PROFHER trial. Bone Joint J 2016;98-B:152-159. [DOI] [PubMed] [Google Scholar]
  • 9. Handoll H, Brealey S, Jefferson L, et al. Defining the fracture population in a pragmatic multi-centre randomised controlled trial: PROFHER and the Neer classification of proximal humeral fractures. Bone Joint Res 2016;5:481–489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Sabharwal S, Patel NK, Griffiths D, et al. Trials based on specific fracture configuration and surgical procedures likely to be more relevant for decision-making in the management of proximal humerus fractures: findings of a meta-analysis. Bone Joint Res 2016;5:470–480. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Bone & Joint Research are provided here courtesy of British Editorial Society of Bone and Joint Surgery

RESOURCES